New Treatments For Alzheimers Disease
|Home||Elderly Abuse||Elderly Care||Elderly Health||Elderly Law||Death & Mourning||Retirement|
Alzheimer's disease is a degenerative disorder that affects millions of seniors around the world. It is, therefore, not unusual for scientists to look for new treatments for Alzheimer's disease. In fact, two new treatments have been formulated by scientists to help Alzheimer patients. However, there is some controversy over these new treatments for Alzheimer's disease.
One of the new drugs is named Dimebon. It is believed to help with the deteriorating cognitive function that all Alzheimer patients suffer from. However, a new research on this drug recently revealed that the drug causes an increase in the amount of beta amyloid in the brain. Beta amyloid is a protein that is believed to be the cause of the disease.
Another new treatment for Alzheimer's disease is in the form of a vaccine. Results show that the vaccine is effective to a certain degree in decreasing the tangles of tau protein, which is also connected to the disease.
At the moment, pharmaceutical companies all over the world are trying to find new treatments to reduce the amount of beta amyloid in the brain. And, with the result of Dimebon, the scientists are left scratching their heads. They do not know what to make of the results of the recent study.
Of course, the scientists are perplexed that Dimebon increases the number of beta amyloid in the brain as majority of the drug manufacturing companies are looking for drugs that will lower the beta amyloid in the brain. And, Dimebon was considered to be a promising drug based on the initial studies and reports. So, it is quite possible that all pharmaceutical companies may have to go back to the drawing board and look at the potential new treatments for Alzheimer's disease that they have been working at.
More Articles :